- List
- By Topic
- On Map
- Search Details

Celiac Disease
Need help? See RSS Feeds
Choose a feed type:

Celiac Disease (210 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03731806 | Not yet recruiting | Capsule Endoscopy in Newly Diagnosed Patients of Celiac Disease |
|
Observational |
|
Other |
|
|
30 | All | 8 Years to 60 Years (Child, Adult) | NCT03731806 | CAP-CELIAC | December 2018 | November 2019 | December 2019 | November 6, 2018 | November 8, 2018 |
|
|||||
2 | NCT03136731 | Recruiting | Evidence-based Screening Strategies for Celiac Disease |
|
|
Observational |
|
Other |
|
|
3517 | All | 6 Months to 100 Years (Child, Adult, Older Adult) | NCT03136731 | Celiac2017 | November 29, 2017 | December 31, 2022 | December 31, 2032 | May 2, 2017 | November 30, 2017 |
|
||||
3 | NCT03562221 | Recruiting | Prevention of Celiac Disease in Skåne |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
600 | All | 4 Months to 4 Months (Child) | NCT03562221 | 2018/61 | PreCiSe | December 4, 2018 | August 2024 | August 2027 | June 19, 2018 | January 17, 2019 |
|
||
4 | NCT03585478 | Not yet recruiting | Latiglutenase as a Treatment for Celiac Disease |
|
|
Interventional |
Phase 2 |
|
Industry / NIH |
|
|
80 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT03585478 | IMGX003-NCCIH-1721 1R33AT009637-01 |
March 2019 | February 2020 | May 2020 | July 13, 2018 | February 11, 2019 |
|
|||
5 | NCT03763487 | Recruiting | The Aim of This Project is to Verify Whether a Depletion of B Cell Memory Subpopulation ("Marginal-zone-like") CD19 + IgD + CD27 + and CD19 + IgM + CD27 + is a Useful Indicator of Hyposplenism in Patients With Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
50 | All | 18 Years and older (Adult, Older Adult) | NCT03763487 | Indicators of celiac activity | June 1, 2018 | December 31, 2018 | December 31, 2018 | December 4, 2018 | December 4, 2018 |
|
|||
6 | NCT01172665 | Unknown † | Celiac Disease Database |
|
Observational |
|
Other |
|
3500 | All | up to 70 Years (Child, Adult, Older Adult) | NCT01172665 | 16103A | September 2008 | September 2017 | July 30, 2010 | August 31, 2016 |
|
|||||||
7 | NCT03320811 | Completed | Interpretation of Serological Tests in the Diagnosis of Celiac Disease: Anti-deamidated Gliadin Peptide Antibodies Revisited |
|
|
Observational |
|
Other |
|
|
2026 | All | Child, Adult, Older Adult | NCT03320811 | 2016Ao005 | DGP-CeliacDis | January 1, 2015 | September 1, 2015 | January 1, 2016 | October 25, 2017 | October 25, 2017 |
|
|||
8 | NCT02805816 | Completed | Choosing a Preferred Serology Kit for Screening and Diagnosis of Celiac Disease |
|
Observational |
|
Other |
|
|
128 | All | 6 Months to 18 Years (Child, Adult) | NCT02805816 | 0466-15 RMC | June 8, 2016 | June 2017 | July 2018 | June 20, 2016 | September 7, 2018 |
|
|||||
9 | NCT03521180 | Recruiting | A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease |
|
Observational |
|
Industry |
|
|
15 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03521180 | NDS-CP-002 U1111-1208-7879 |
May 11, 2018 | February 28, 2019 | February 28, 2019 | May 10, 2018 | December 5, 2018 |
|
|||||
10 | NCT01765647 | Completed | Oral AGY for Celiac Disease |
|
|
Interventional |
Phase 1 |
|
Industry / Other |
|
|
10 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01765647 | AGY | May 2014 | August 2015 | August 2015 | January 10, 2013 | April 21, 2016 |
|
|||
11 | NCT01909050 | Completed | Immune Response in Celiac Disease on In-vitro Gluten Challenge |
|
Observational |
|
Other |
|
|
42 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01909050 | 2012P000354 | February 2013 | January 2018 | March 2018 | July 26, 2013 | March 19, 2018 |
|
|||||
12 | NCT01661933 | Completed Has Results |
Desensitising Celiac Disease Patients With the Human Hookworm |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
12 | All | 18 Years and older (Adult, Older Adult) | NCT01661933 | AU/3/BOBD012 | NaCeD | August 2012 | March 2014 | March 2014 | August 10, 2012 | October 20, 2014 | October 13, 2014 |
|
|
13 | NCT03486990 | Active, not recruiting | Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
22 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03486990 | TGLIA-5.001 | February 9, 2018 | May 29, 2019 | May 29, 2019 | April 3, 2018 | January 31, 2019 |
|
|||
14 | NCT02242123 | Recruiting | Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay. |
|
Observational |
|
Other |
|
|
50 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02242123 | ACPM05 | January 2012 | December 2016 | June 2019 | September 16, 2014 | September 5, 2018 |
|
|||||
15 | NCT01917630 | Unknown † | Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
500 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT01917630 | ALV003-1221 | August 2013 | April 2015 | June 2015 | August 7, 2013 | December 17, 2014 |
|
|||
16 | NCT02061306 | Recruiting | Celiac Disease Genomic Environmental Microbiome and Metabolomic Study |
|
Observational |
|
Other |
|
|
400 | All | up to 6 Months (Child) | NCT02061306 | 2013P001965 | CDGEMM | March 2014 | December 2024 | December 2024 | February 12, 2014 | August 15, 2018 |
|
||||
17 | NCT02220166 | Completed | Safety of Prolonged Administration of Triticum Monococcum in Celiac Disease |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
8 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02220166 | GE-GA2-2010 | November 2010 | July 2011 | August 2011 | August 19, 2014 | August 19, 2014 |
|
|||
18 | NCT02464150 | Recruiting | Gluten Challenge in Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
10 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02464150 | 2013/1237 | April 1, 2017 | April 2018 | June 2018 | June 8, 2015 | May 30, 2017 |
|
|||
19 | NCT01129908 | Completed | Saliva Composition and Oral Hygiene in Children With Celiac Disease Before and After the Change in Diet |
|
Observational |
|
Other |
|
90 | All | 3 Years to 18 Years (Child, Adult) | NCT01129908 | odelia- HMO-CTIL | May 2010 | July 2012 | July 2012 | May 25, 2010 | December 20, 2016 | |||||||
20 | NCT02637141 | Completed | A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
64 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT02637141 | CELIM-NRCD-001 2015-003647-19 |
March 9, 2016 | February 15, 2017 | March 14, 2017 | December 22, 2015 | February 1, 2018 |
|
|||
21 | NCT01257620 | Completed | Clinical Trial on the Effects of Bifidobacterium Infantis in Active Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
22 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01257620 | Celiac | Celiac | December 2010 | September 2011 | December 2011 | December 10, 2010 | February 13, 2012 |
|
||
22 | NCT03271138 | Completed | Bifidobacterium Infantis NLS Super Strain for Celiac Disease Patients on a Gluten-free Diet With Persistent Gastrointestinal Symptoms |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
18 | All | 18 Years and older (Adult, Older Adult) | NCT03271138 | GlobalIP 001 |
July 21, 2017 | December 7, 2017 | December 7, 2017 | September 1, 2017 | August 24, 2018 |
|
|||
23 | NCT03520244 | Completed | A 12-week Exercise Program for Adults With Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
48 | All | 18 Years and older (Adult, Older Adult) | NCT03520244 | REB16-1774 | MOVE-C | November 15, 2016 | March 30, 2018 | March 30, 2018 | May 9, 2018 | September 28, 2018 |
|
||
24 | NCT01695681 | Unknown † | Screen-detected Coeliac Disease, a Population Based Study |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
200 | All | 30 Years to 87 Years (Adult, Older Adult) | NCT01695681 | 2011/1943 (REK) | October 2012 | September 2017 | September 2017 | September 28, 2012 | November 29, 2016 |
|
|||
25 | NCT03364556 | Completed | Nutritional Intake and Bone Health in Celiac Disease |
|
|
Observational |
|
Other |
|
|
13893 | All | 18 Years and older (Adult, Older Adult) | NCT03364556 | 1159415 | June 2016 | November 2017 | November 2017 | December 6, 2017 | December 6, 2017 | |||||
26 | NCT03409796 | Recruiting | Assessment of Immune Activation and Tolerance in Celiac Disease |
|
|
Interventional |
Early Phase 1 |
|
Industry |
|
|
20 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03409796 | TIMP-GLIA-5001 U1111-1202-6708 |
April 24, 2018 | January 28, 2019 | January 28, 2019 | January 24, 2018 | November 19, 2018 |
|
|||
27 | NCT01045837 | Completed | Effect of Addition of Short Course of Prednisolone to Gluten Free Diet in Naive Celiac Disease Patients |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
33 | All | 12 Years and older (Child, Adult, Older Adult) | NCT01045837 | Celiac-Prednisolone | CD | April 2009 | April 2010 | August 2010 | January 11, 2010 | January 19, 2012 |
|
||
28 | NCT01902368 | Terminated | Celiac Disease Screening |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
14 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT01902368 | 2012P000326 | September 2013 | April 2014 | August 2014 | July 18, 2013 | March 19, 2018 |
|
|||
29 | NCT01560169 | Completed | Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients |
|
Observational |
|
Industry |
|
|
110 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01560169 | ALV003-1121 | March 2012 | September 2013 | September 2013 | March 22, 2012 | October 10, 2013 |
|
|||||
30 | NCT03707730 | Not yet recruiting | A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease |
|
|
Interventional |
Phase 2 |
|
Industry / Other |
|
|
149 | All | 10 Years to 65 Years (Child, Adult, Older Adult) | NCT03707730 | AGY-010 | AGY-010 | December 2018 | December 2022 | December 2022 | October 16, 2018 | October 17, 2018 | |||
31 | NCT03738475 | Recruiting | Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
30 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT03738475 | TGLIA-5.002 | January 4, 2019 | May 2019 | May 2019 | November 12, 2018 | February 1, 2019 |
|
|||
32 | NCT03095573 | Recruiting | Comparison Between Axial- and Lateral-viewing Capsule Endoscopy in Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
25 | All | 18 Years and older (Adult, Older Adult) | NCT03095573 | Capsocam | March 1, 2017 | October 31, 2018 | February 28, 2019 | March 29, 2017 | March 30, 2017 |
|
|||
33 | NCT02472119 | Unknown † | Wheat Flour Treatment With Microbial Transglutaminase and Lysine Ethyl Ester: New Frontiers in Celiac Disease Treatment. |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
20 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02472119 | 672/10 Rif. 1907 / 22.07.2010 | WHETMIT | June 2015 | August 2015 | August 2015 | June 15, 2015 | June 15, 2015 |
|
||
34 | NCT03176095 | Completed | Celiac Disease Prevention With Probiotics |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
90 | All | 2 Years to 12 Years (Child) | NCT03176095 | 2011/335 | CiPP | March 1, 2012 | August 30, 2015 | August 30, 2015 | June 5, 2017 | June 16, 2017 | |||
35 | NCT03152279 | Enrolling by invitation | Assessment of Duodenal Epithelial Integrity in Celiac Disease With Mucosal Impedance |
|
|
Observational |
|
Other |
|
|
50 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT03152279 | 161436 | December 2016 | June 2019 | June 2019 | May 15, 2017 | December 19, 2018 |
|
||||
36 | NCT03168490 | Recruiting | In Vivo Effects of the Gluten Friendly Bread in Coeliac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
60 | All | 20 Years to 80 Years (Adult, Older Adult) | NCT03168490 | LSC 15/146 | February 1, 2016 | January 20, 2018 | April 1, 2018 | May 30, 2017 | May 30, 2017 |
|
|||
37 | NCT00669825 | Completed | Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
36 | All | 18 Years to 45 Years (Adult) | NCT00669825 | ALV003-0812 | FED | March 2008 | October 2008 | October 2008 | May 1, 2008 | February 19, 2010 |
|
||
38 | NCT00626184 | Completed | A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
28 | All | 18 Years to 45 Years (Adult) | NCT00626184 | ALV003-0811 | February 2008 | May 2008 | July 2008 | February 29, 2008 | August 18, 2009 |
|
|||
39 | NCT03321214 | Not yet recruiting | Gluten Sensor Device to Promote Gluten Free Diet Adherence and Quality of Life in Patients With Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
30 | All | 13 Years to 65 Years (Child, Adult, Older Adult) | NCT03321214 | AAAR6004 | December 1, 2017 | June 1, 2018 | December 1, 2018 | October 25, 2017 | October 30, 2017 |
|
|||
40 | NCT02675283 | Completed | Case Finding for Coeliac Disease Using a Point of Care Test in a Pharmacy Setting |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
502 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02675283 | STH19172 | July 2016 | October 2017 | October 2017 | February 5, 2016 | November 24, 2017 |
|
|||
41 | NCT02834429 | Completed | Pre-endoscopy Serological Testing for Coeliac Disease; a Novel Approach Using Rapid Antibody Testing |
|
Observational |
|
Other |
|
|
1596 | All | 18 Years and older (Adult, Older Adult) | NCT02834429 | STH15416 | February 2010 | August 2017 | October 2017 | July 15, 2016 | November 24, 2017 |
|
|||||
42 | NCT03064997 | Completed | Prebiotic as a Supplement of Gluten-free Diet in the Management of Celiac Disease in Children |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
34 | All | 3 Years to 18 Years (Child, Adult) | NCT03064997 | IAR&FR internal project 20 | January 12, 2016 | March 1, 2016 | June 1, 2016 | February 27, 2017 | February 27, 2017 |
|
|||
43 | NCT01255696 | Completed | Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
61 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01255696 | ALV003-1021 2010-023127-23 |
November 2010 | May 2011 | June 2011 | December 7, 2010 | August 6, 2012 |
|
|||
44 | NCT00617838 | Unknown † | Celiac Disease Prevention |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
168 | All | up to 2 Months (Child) | NCT00617838 | KUH5021612 | October 2007 | August 2014 | December 2014 | February 18, 2008 | August 23, 2013 |
|
|||
45 | NCT02475369 | Enrolling by invitation | Pancreatic Enzyme Supplementation for Celiac Disease |
|
|
Interventional |
Phase 4 |
|
Other / Industry |
|
|
14 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02475369 | 2014P000375 | May 2015 | June 2019 | December 2019 | June 18, 2015 | October 11, 2018 |
|
|||
46 | NCT02754609 | Active, not recruiting | Hookworm Therapy for Coeliac Disease |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
60 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02754609 | CT-2016-CTN-01363-1 | NainCeD-3 | September 2016 | December 2020 | December 2020 | April 28, 2016 | March 12, 2018 |
|
||
47 | NCT01439035 | Completed Has Results |
Evaluate the Use of Optical Frequency Domain Imaging (OFDI) for Celiac Disease in Children, Adolescents and Young Adults |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
6 | All | 7 Years and older (Child, Adult, Older Adult) | NCT01439035 | 2009-P-000938 | August 2009 | February 4, 2010 | February 4, 2011 | September 22, 2011 | October 24, 2018 | September 26, 2018 |
|
||
48 | NCT00959114 | Completed | Safety and Efficacy of ALV003 for the Treatment of Celiac Disease |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
74 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT00959114 | ALV003-0921 | August 2009 | August 2010 | October 2010 | August 14, 2009 | August 6, 2012 |
|
|||
49 | NCT02244047 | Completed | Cytokine Profile in Children With Celiac Disease |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
66 | All | 1 Year to 18 Years (Child, Adult) | NCT02244047 | CEL-BIF | October 2013 | June 2014 | June 2014 | September 18, 2014 | September 18, 2014 | ||||
50 | NCT02458898 | Completed | Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
61 | All | 12 Years to 24 Years (Child, Adult) | NCT02458898 | 29967 | February 2015 | May 2016 | May 2016 | June 1, 2015 | May 27, 2016 |
|
|||
51 | NCT02528799 | Completed | Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
38 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02528799 | Nexvax2-1004 U1111-1173-7522 |
August 2015 | January 6, 2017 | January 6, 2017 | August 19, 2015 | December 24, 2018 |
|
|||
52 | NCT02679014 | Completed | A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac Disease |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
19 | All | 18 Years to 60 Years (Adult) | NCT02679014 | BP29911 2015-002864-18 |
March 6, 2016 | August 28, 2016 | August 28, 2016 | February 10, 2016 | August 25, 2017 |
|
|||
53 | NCT01116505 | Completed | Treatment of Screen-detected Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Older Adult) | NCT01116505 | R07122 | August 2008 | July 2012 | August 2012 | May 5, 2010 | August 27, 2012 |
|
|||
54 | NCT01145287 | Completed | Impact of the Diagnosis of Celiac Disease |
|
Observational |
|
Other |
|
|
760 | All | Child, Adult, Older Adult | NCT01145287 | Burden-1 | February 2007 | April 2016 | April 2016 | June 16, 2010 | April 21, 2016 |
|
|||||
55 | NCT01338324 | Completed | Protocol for Correlating Enteropathic Severity and Small Intestinal CYP3A4 Activity in Patients With Celiac Disease |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
41 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01338324 | N-1229 | Cyp | April 2010 | June 2011 | September 2011 | April 19, 2011 | December 13, 2011 |
|
||
56 | NCT01975155 | Unknown † | Dietary Assessment and Mycotoxin Exposure in Celiac Disease |
|
|
Observational |
|
Other |
|
|
100 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01975155 | 852/12 GFD/2012 |
June 2013 | December 2015 | July 2016 | November 4, 2013 | August 27, 2015 |
|
||||
57 | NCT01317914 | Completed | Prospective Study of Undiagnosed Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
31 | All | 60 Years and older (Adult, Older Adult) | NCT01317914 | 10-000178 | July 2010 | April 2012 | April 2012 | March 17, 2011 | October 2, 2017 |
|
|||
58 | NCT00671138 | Completed | Inoculating Celiac Disease Patients With the Human Hookworm Necator Americanus: Evaluating Immunity and Gluten-sensitivity |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT00671138 | 2007/115 IBD-0214R |
October 2007 | December 2008 | September 2009 | May 5, 2008 | February 2, 2016 |
|
|||
59 | NCT02690532 | Completed | Gut Permeability Assessment in Celiac and Gluten Sensitive Children |
|
Observational |
|
Other |
|
|
40 | All | 2 Years to 17 Years (Child) | NCT02690532 | 15-006018 | March 2016 | July 1, 2018 | August 1, 2018 | February 24, 2016 | August 15, 2018 |
|
|||||
60 | NCT00810654 | Completed | Effect of Aspergillus Niger Prolyl Endoprotease (AN-PEP) Enzyme on the Effects of Gluten Ingestion in Patients With Coeliac Disease |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / Industry |
|
|
14 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT00810654 | RD.0601.54 NTR1281 |
May 2008 | May 2009 | December 2009 | December 18, 2008 | January 19, 2011 |
|
|||
61 | NCT01396213 | Completed | A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
342 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01396213 | Clin1001-012 | November 7, 2011 | August 20, 2013 | August 20, 2013 | July 18, 2011 | September 20, 2017 |
|
|||
62 | NCT01137955 | Completed | Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other / Industry |
|
|
41 | All | 18 Years and older (Adult, Older Adult) | NCT01137955 | AAAB6531(Y3M00) IRB-AAAB6531(Y3M00) |
October 2006 | April 2008 | April 2008 | June 7, 2010 | January 21, 2011 |
|
|||
63 | NCT02711696 | Completed | Randomized Clincal Trial on the Effect of a Restricted Gluten Contamination Elimination Diet Among Celiacs [GluCED] |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
30 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02711696 | CD_GE_2013 | GluCED | March 2014 | June 2015 | January 2016 | March 17, 2016 | October 27, 2016 | |||
64 | NCT00620451 | Completed | Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
105 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT00620451 | AT1001-011 | February 2008 | July 2009 | December 2009 | February 21, 2008 | September 20, 2017 |
|
|||
65 | NCT00628823 | Completed | Treatment of Mild Enteropathy Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
73 | All | 16 Years and older (Child, Adult, Older Adult) | NCT00628823 | SA-115376 | TMCD | March 2003 | June 2008 | December 2008 | March 5, 2008 | May 17, 2016 |
|
||
66 | NCT00639444 | Completed | Risk of Celiac Disease and Age at Gluten Introduction |
|
|
Interventional |
Not Applicable |
|
Other / Industry |
|
|
703 | All | up to 6 Months (Child) | NCT00639444 | UPM-CE 204332 | CELIPREV | September 2004 | December 2007 | November 2013 | March 20, 2008 | December 10, 2013 |
|
||
67 | NCT00889473 | Completed | Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
42 | All | 18 Years to 72 Years (Adult, Older Adult) | NCT00889473 | CLIN1001-006 Part B | April 2009 | November 2009 | April 2010 | April 29, 2009 | September 20, 2017 |
|
|||
68 | NCT00739128 | Terminated | Response to Hepatitis B Vaccine in Celiac Disease Patients |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
210 | All | 1 Year and older (Child, Adult, Older Adult) | NCT00739128 | 15363.ct.il | February 2009 | March 2011 | March 2011 | August 21, 2008 | April 15, 2011 |
|
|||
69 | NCT03244254 | Not yet recruiting | Intestinal Fatty Acid-binding Protein (I-FABP) Levels in Pediatric Celiac Patients |
|
Observational |
|
Other |
|
|
70 | All | up to 17 Years (Child) | NCT03244254 | SchneiderCMCIsraelIFABP | November 2017 | August 2019 | August 2020 | August 9, 2017 | October 4, 2017 |
|
|||||
70 | NCT00540657 | Completed | A Phase II Study of CCX282-B in Patients With Celiac Disease |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
90 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT00540657 | CL009_282 | October 2007 | June 2008 | July 2008 | October 8, 2007 | July 22, 2008 |
|
|||
71 | NCT01159457 | Unknown † | Comparison of Engerix B Vaccine Versus Sci-B-Vac Vaccine in Celiac Patients |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
210 | All | 1 Year to 20 Years (Child, Adult) | NCT01159457 | 15364.ct.il | April 2011 | June 2012 | January 2013 | July 9, 2010 | April 15, 2011 |
|
|||
72 | NCT02389062 | Unknown † | Noninvasive Markers of Gluten Ingestion in Celiac Disease Patients |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
36 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02389062 | 14D.389 | February 2015 | February 2017 | February 2019 | March 17, 2015 | March 17, 2015 |
|
|||
73 | NCT00492960 | Completed | Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
171 | All | 18 Years to 72 Years (Adult, Older Adult) | NCT00492960 | CLIN1001-006 | August 2007 | October 2008 | March 2009 | June 27, 2007 | September 20, 2017 |
|
|||
74 | NCT00386165 | Completed | Safety Study of Larazotide Acetate to Treat Celiac Disease. |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
21 | All | 18 Years to 59 Years (Adult) | NCT00386165 | CLIN1001-002 | November 29, 2005 | January 26, 2006 | January 26, 2006 | October 11, 2006 | September 11, 2017 |
|
|||
75 | NCT00362856 | Completed | Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
80 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT00362856 | CLIN1001-004 | September 13, 2006 | March 6, 2007 | March 6, 2007 | August 10, 2006 | September 12, 2017 |
|
|||
76 | NCT00879749 | Completed | Safety Study of Nexvax2 in Subjects With Coeliac Disease |
|
|
Interventional |
Phase 1 |
|
Industry |
|
34 | All | 18 Years to 60 Years (Adult) | NCT00879749 | Nexvax2-001 | April 2009 | March 2010 | June 2010 | April 10, 2009 | April 7, 2011 |
|
||||
77 | NCT00175760 | Completed | Can a Very High Result From a Screening Test for Celiac Disease be Used to Diagnose Celiac Disease? |
|
|
Observational |
|
Other |
|
100 | All | 2 Months to 18 Years (Child, Adult) | NCT00175760 | C04-0304 | December 2004 | October 2006 | October 2006 | September 15, 2005 | April 12, 2011 |
|
|||||
78 | NCT03483805 | Completed | Effects of a Nutritional Solution to Improve Intestinal Permeability in Celiac Patients |
|
|
Interventional |
Not Applicable |
|
Industry / Other |
|
|
44 | All | 18 Years to 60 Years (Adult) | NCT03483805 | 2016-A00330-51 | Protalsafe | December 21, 2016 | January 12, 2018 | January 12, 2018 | March 30, 2018 | April 20, 2018 |
|
||
79 | NCT02946827 | Unknown † | A Low FODMAPs Diet in Celiac Patients With Persistent Gastrointestinal Symptoms |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
68 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02946827 | 2016/464 | January 2016 | November 2016 | January 2017 | October 27, 2016 | October 27, 2016 |
|
|||
80 | NCT02451449 | Active, not recruiting | Celiac Disease and Infertility Among Men and Women in Denmark |
|
Observational |
|
Other |
|
|
900 | All | 18 Years to 40 Years (Adult) | NCT02451449 | CØF 2015 | CØF2015 | January 2015 | September 2017 | November 2018 | May 22, 2015 | October 26, 2017 |
|
||||
81 | NCT02126033 | Unknown † | Telomeres Parameters in Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Older Adult) | NCT02126033 | 1234 | December 2015 | April 29, 2014 | April 29, 2014 | ||||||
82 | NCT01990885 | Completed | Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients. |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
40 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01990885 | BL-7010.01 | December 2013 | October 2014 | October 2014 | November 25, 2013 | August 18, 2017 |
|
|||
83 | NCT03137862 | Completed | "Gluten Friendly" Treatment in Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
45 | All | Child, Adult, Older Adult | NCT03137862 | NCT64/CE | GLUFR | March 20, 2017 | April 2, 2017 | January 15, 2018 | May 3, 2017 | August 9, 2018 |
|
||
84 | NCT02442219 | Recruiting | A Blood Based Diagnostic Test for Coeliac Disease |
|
Observational |
|
Other |
|
|
144 | All | 18 Years and older (Adult, Older Adult) | NCT02442219 | 2011/2472 | February 2015 | November 27, 2021 | November 27, 2021 | May 13, 2015 | January 14, 2019 |
|
|||||
85 | NCT00859391 | Completed | Effects of Gluten Digestion With ALV003 |
|
Observational |
|
Industry |
|
|
20 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT00859391 | ALV0801 | 0801 | May 2008 | June 2008 | June 2008 | March 11, 2009 | June 11, 2009 |
|
||||
86 | NCT03221647 | Completed | INF-α Innate Immune Response to Gliadin |
|
|
Observational |
|
Other |
|
|
53 | All | 2 Years to 17 Years (Child) | NCT03221647 | Innate immunity CD | January 10, 2013 | July 1, 2017 | July 1, 2017 | July 18, 2017 | July 18, 2017 |
|
||||
87 | NCT02929316 | Terminated | Vedolizumab Induction May Prevent Celiac Enteritis |
|
|
Interventional |
Phase 2 |
|
Other / Industry |
|
|
1 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT02929316 | IISR-2016-101481 | June 25, 2018 | October 5, 2018 | October 5, 2018 | October 11, 2016 | October 10, 2018 |
|
|||
88 | NCT00931892 | Completed | Serum Markers in Gluten Challenge |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
22 | All | 17 Years to 72 Years (Child, Adult, Older Adult) | NCT00931892 | 2007P000280 | April 2009 | August 2011 | August 2011 | July 2, 2009 | October 23, 2018 |
|
|||
89 | NCT00555737 | Completed | Performance Evaluation of Capsule Endoscopy in the Diagnosis of Gluten Sensitive Enteropathy (MA-23) |
|
|
Observational |
|
Industry |
|
|
102 | All | 18 Years and older (Adult, Older Adult) | NCT00555737 | MA-23 | November 2003 | July 2007 | November 9, 2007 | March 26, 2009 |
|
|||||
90 | NCT02916654 | Recruiting | Sucrosomial Iron in Patients With Celiac Disease and IDA |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
20 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT02916654 | 33_2014 | April 2015 | August 2016 | December 2017 | September 27, 2016 | March 27, 2017 |
|
|||
91 | NCT00819819 | Terminated | Infant Nutrition and Risk of Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
80 | All | up to 6 Months (Child) | NCT00819819 | 2013P000287 | April 2008 | July 2013 | July 2013 | January 9, 2009 | March 22, 2017 |
|
|||
92 | NCT00962182 | Completed | Study of Enzyme Supplements to Treat Celiac Disease |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
38 | All | 12 Years to 65 Years (Child, Adult, Older Adult) | NCT00962182 | HP-03 | August 2008 | December 2014 | December 2017 | August 19, 2009 | March 6, 2018 |
|
|||
93 | NCT02472704 | Completed | Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
18 | All | 18 Years and older (Adult, Older Adult) | NCT02472704 | DSG-DC/01/01 | September 2011 | April 2014 | May 2014 | June 16, 2015 | June 16, 2015 | ||||
94 | NCT02949765 | Recruiting | Effects of a Dietary Approach to Iron Deficiency in Premenopausal Women Affected by Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
35 | Female | 18 Years to 50 Years (Adult) | NCT02949765 | Atto 302/2016 | December 2015 | June 2017 | September 2017 | October 31, 2016 | March 14, 2017 |
|
|||
95 | NCT03011931 | Recruiting | Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568] |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Older Adult) | NCT03011931 | 15-007568 | March 2016 | January 2019 | March 2019 | January 6, 2017 | January 8, 2019 |
|
|||
96 | NCT02072590 | Recruiting | Improved Diagnostics of Celiac Disease in Children |
|
Observational |
|
Other |
|
|
2000 | All | up to 17 Years (Child) | NCT02072590 | R11187 | August 2011 | December 2022 | December 2022 | February 26, 2014 | June 4, 2018 |
|
|||||
97 | NCT03569007 | Not yet recruiting | Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
924 | All | 18 Years and older (Adult, Older Adult) | NCT03569007 | CeD-LA-3001 | June 2019 | August 2021 | December 2021 | June 25, 2018 | February 5, 2019 | ||||
98 | NCT02325232 | Unknown † | Enteroscopy for Early Diagnosis of Tumors in Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
200 | All | 18 Years and older (Adult, Older Adult) | NCT02325232 | 167 GR-2011-02348234 |
February 2012 | May 2017 | November 2017 | December 24, 2014 | August 27, 2015 |
|
|||
99 | NCT00250146 | Terminated | Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
39 | All | 18 Years and older (Adult, Older Adult) | NCT00250146 | IRB-2000-611 | February 2001 | March 2005 | November 7, 2005 | November 7, 2005 |
|
||||
100 | NCT01566110 | Completed | Celiac Disease and Diabetes- Dietary Intervention and Evaluation Trial |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
50 | All | 8 Years to 45 Years (Child, Adult) | NCT01566110 | 1000030346 | CD-DIET | March 2012 | March 2018 | March 2018 | March 29, 2012 | September 5, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.